Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma
Clinical trial NCT03061656 · UNKNOWN
Trial details
- NCT number
- NCT03061656
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2013-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.